Grünenthal Pharmaceutical Project
Comprehensive regulatory intelligence and strategic guidance for branded generic product registrations and ongoing regulatory maintenance in the Kenyan pharmaceutical market.
01The challenge
Grünenthal faced complex regulatory requirements for entering the Kenyan pharmaceutical market with their branded generic products. The Pharmacy and Poisons Board had stringent registration processes, and maintaining compliance for pain management and specialty pharmaceutical products required deep local expertise and continuous monitoring of regulatory changes.
02Our solution
ECP provided end-to-end regulatory consulting services, including product registration management, compliance strategy development, and ongoing regulatory maintenance. Our team facilitated communication with regulatory authorities, developed tailored strategies for Grünenthal's portfolio, and established systems for continuous compliance monitoring and stakeholder engagement.
03Results
The partnership resulted in successful market entry and sustainable operations in Kenya. Multiple branded generic products were registered, a robust compliance framework was established, and Grünenthal achieved their strategic objectives in the East African market. The project showcased ECP's expertise in supporting global pharmaceutical companies navigate complex regulatory environments.
- Successful registration of multiple branded generic products
- Established comprehensive regulatory compliance systems
- Enhanced stakeholder relationships with Kenyan authorities
- Sustained market presence and business continuity
“ECP's regulatory expertise and local knowledge were instrumental in our successful entry into the Kenyan market. Their professional approach and deep understanding of local requirements made the complex registration process seamless.”Grünenthal Project Manager
Other case studies.
World Bank - EBA Project
Delivered regulatory framework intelligence for the Efficient Business for Agriculture (EBA) project, impacting veterinary product registration and importation in Kenya.
GSK Projects
Supported PAREXEL's GSK Vx Divestment project, regulatory strategy for Kenya and Nigeria, and restructuring of pharmaceutical operations in Sub-Saharan Africa.
PAREXEL Multi-Client Projects
Provided consulting services for Novartis, Merck, P&G, Angelini, MSD and LEO Pharma including clinical trial label knowledge and regulatory strategy development.
Ready to navigate Africa’s regulatory landscape?
Tell us about your product and target markets. An ECP specialist will respond with a clear next step.